BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Graham DY, Zou WY. Guilt by association: intestinal metaplasia does not progress to gastric cancer. Curr Opin Gastroenterol. 2018;34:458-464. [PMID: 30138135 DOI: 10.1097/mog.0000000000000472] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Furihata C. Human gastric cancer risk screening: From rat pepsinogen studies to the ABC method. Proc Jpn Acad Ser B Phys Biol Sci 2021;97:462-78. [PMID: 34629355 DOI: 10.2183/pjab.97.023] [Reference Citation Analysis]
2 Waldum HL, Fossmark R. Role of Autoimmune Gastritis in Gastric Cancer. Clin Transl Gastroenterol 2019;10:e00080. [PMID: 31517647 DOI: 10.14309/ctg.0000000000000080] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Waldum H, Mjønes P. Towards Understanding of Gastric Cancer Based upon Physiological Role of Gastrin and ECL Cells. Cancers (Basel) 2020;12:E3477. [PMID: 33266504 DOI: 10.3390/cancers12113477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kohoutova D, Banks M, Bures J. Advances in the Aetiology & Endoscopic Detection and Management of Early Gastric Cancer. Cancers (Basel) 2021;13:6242. [PMID: 34944861 DOI: 10.3390/cancers13246242] [Reference Citation Analysis]
5 Sáenz JB. Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia's Pattern of Spread Throughout the Stomach. Front Cell Dev Biol 2021;9:741574. [PMID: 34869328 DOI: 10.3389/fcell.2021.741574] [Reference Citation Analysis]
6 Waldum H, Fossmark R. Gastritis, Gastric Polyps and Gastric Cancer. Int J Mol Sci 2021;22:6548. [PMID: 34207192 DOI: 10.3390/ijms22126548] [Reference Citation Analysis]
7 Weise F, Vieth M, Reinhold D, Haybaeck J, Goni E, Lippert H, Ridwelski K, Lingohr P, Schildberg C, Vassos N, Kruschewski M, Krasniuk I, Grimminger PP, Waidmann O, Peitz U, Veits L, Kreuser N, Lang H, Bruns C, Moehler M, Lordick F, Gockel I, Schumacher J, Malfertheiner P, Venerito M. Gastric cancer in autoimmune gastritis: A case-control study from the German centers of the staR project on gastric cancer research. United European Gastroenterol J 2020;8:175-84. [PMID: 32213076 DOI: 10.1177/2050640619891580] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
8 Zhang L, Sun B, Zhou X, Wei Q, Liang S, Luo G, Li T, Lü M. Barrett's Esophagus and Intestinal Metaplasia. Front Oncol 2021;11:630837. [PMID: 34221959 DOI: 10.3389/fonc.2021.630837] [Reference Citation Analysis]
9 Graham DY, Rugge M, Genta RM. Diagnosis: gastric intestinal metaplasia - what to do next? Curr Opin Gastroenterol 2019;35:535-43. [PMID: 31415250 DOI: 10.1097/MOG.0000000000000576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 5.5] [Reference Citation Analysis]
10 Negovan A, Iancu M, Fülöp E, Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol 2019; 25(30): 4105-4124 [PMID: 31435167 DOI: 10.3748/wjg.v25.i30.4105] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
11 Engstrand L, Graham DY. Microbiome and Gastric Cancer. Dig Dis Sci 2020;65:865-73. [PMID: 32040665 DOI: 10.1007/s10620-020-06101-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
12 Wada Y, Nakajima S, Kushima R, Takemura S, Mori N, Hasegawa H, Nakayama T, Mukaisho KI, Yoshida A, Umano S, Yamamoto K, Sugihara H, Murakami K. Pyloric, pseudopyloric, and spasmolytic polypeptide-expressing metaplasias in autoimmune gastritis: a case series of 22 Japanese patients. Virchows Arch 2021;479:169-78. [PMID: 33515301 DOI: 10.1007/s00428-021-03033-5] [Reference Citation Analysis]
13 Hata M, Hayakawa Y, Koike K. Gastric Stem Cell and Cellular Origin of Cancer. Biomedicines 2018;6:E100. [PMID: 30384487 DOI: 10.3390/biomedicines6040100] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
14 Aasarød KM, Waldum HL, Stunes AK, Sandvik AK, Flatberg A, Mjønes P, Syversen U, Bakke I, Fossmark R. Gastric Corpus Mucosal Hyperplasia and Neuroendocrine Cell Hyperplasia, but not Spasmolytic Polypeptide-Expressing Metaplasia, Is Prevented by a Gastrin Receptor Antagonist in H+/K+ATPase Beta Subunit Knockout Mice. Int J Mol Sci 2020;21:E927. [PMID: 32023822 DOI: 10.3390/ijms21030927] [Reference Citation Analysis]